Wolverine Trading, LLC Acelrx Pharmaceuticals Inc Put Options Transaction History

Wolverine Trading, LLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 14, 2021	BUY	$1.25 - $2.77 $14,125 - $31,301	11,300 New	11,300 $18,000
Q2 2020 Aug 13, 2020	SELL	$1.03 - $1.69 $10,918 - $17,914	-10,600 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$0.76 - $2.07 $11,020 - $30,014	-14,500 Reduced 57.77%	10,600 $13,000
Q4 2019 Feb 12, 2020	BUY	$1.66 - $2.4 $15,272 - $22,080	9,200 Added 57.86%	25,100 $53,000
Q3 2019 Nov 14, 2019	SELL	$2.1 - $2.87 $33,810 - $46,207	-16,100 Reduced 50.31%	15,900 $35,000
Q2 2019 Aug 20, 2019	BUY	$2.1 - $3.93 $24,150 - $45,195	11,500 Added 56.1%	32,000 $81,000
Q1 2019 May 15, 2019	BUY	$2.35 - $3.83 $48,175 - $78,515	20,500 New	20,500 $71,000
Q4 2018 Feb 14, 2019	SELL	$2.13 - $4.8 $74,976 - $168,960	-35,200 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.6 - $4.6 $91,520 - $161,920	35,200 New	35,200 $136,000
Q1 2018 May 15, 2018	SELL	$1.7 - $2.35 $48,620 - $67,210	-28,600 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$1.75 - $5.5 $9,800 - $30,800	-5,600 Reduced 16.37%	28,600 $58,000
Q3 2017 Nov 15, 2017	BUY	$2.9 - $4.6 $99,180 - $157,320	34,200	34,200 $157,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.